At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4167 Health Care Technology
Closed 01-12 16:00:00 EST
3,378.30
-91.38
-2.63%
High3,472.84Low3,363.94Vol28.93M
Open3,467.35D1 Closing3,469.69Amplitude3.14%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O731.54MT/O Rate--Tradable Shares0.00
P/B3.733139ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Phreesia SVP Human Resources Amy Beth VanDuyn Reports Disposal of Common Shares
Reuters  ·  06:07
Phreesia SVP Human Resources Amy Beth VanDuyn Reports Disposal of Common Shares
Phreesia Inc. President, Network Solutions David Linetsky Reports Disposal of Common Shares
Reuters  ·  06:02
Phreesia Inc. President, Network Solutions David Linetsky Reports Disposal of Common Shares
Certara Inc. Files Initial Statement of Beneficial Ownership for CEO and Director Jon Matthew Resnick
Reuters  ·  05:59
Certara Inc. Files Initial Statement of Beneficial Ownership for CEO and Director Jon Matthew Resnick
Phreesia Principal Accounting Officer Yvonne Hui Reports Sale of Common Shares
Reuters  ·  05:58
Phreesia Principal Accounting Officer Yvonne Hui Reports Sale of Common Shares
Phreesia CFO Balaji Gandhi Reports Sale of Common Shares
Reuters  ·  05:52
Phreesia CFO Balaji Gandhi Reports Sale of Common Shares
Forian Inc. Held Special Shareholder Meeting
Reuters  ·  05:16
Forian Inc. Held Special Shareholder Meeting
Inspire Medical Systems Inc. Officer John Rondoni Reports Disposal of Common Shares
Reuters  ·  05:05
Inspire Medical Systems Inc. Officer John Rondoni Reports Disposal of Common Shares
Doximity flat after OpenAI acquires healthcare startup Torch
TIPRANKS  ·  04:45
Doximity flat after OpenAI acquires healthcare startup Torch
Sophia Genetics Names Ross Muken CEO as Jurgi Camblong Becomes Executive Chairman
Reuters  ·  01-12 23:48
Sophia Genetics Names Ross Muken CEO as Jurgi Camblong Becomes Executive Chairman
Waystar Introduces Agentic AI to Cloud-Native Platform
MT Newswires Live  ·  01-12 23:22
Waystar Introduces Agentic AI to Cloud-Native Platform
HeartFlow updates investors, emphasizing AI coronary diagnostics
TIPRANKS  ·  01-12 22:13
HeartFlow updates investors, emphasizing AI coronary diagnostics
Heartflow Inc. showcases AI-driven CAD care advancements and growth strategy in new investor presentation
Reuters  ·  01-12 21:50
Heartflow Inc. showcases AI-driven CAD care advancements and growth strategy in new investor presentation
BRIEF-Schrödinger Provides Update On Progress Across The Business And Outlines 2026 Strategic Priorities
Reuters  ·  01-12 21:32
BRIEF-Schrödinger Provides Update On Progress Across The Business And Outlines 2026 Strategic Priorities
Schrödinger Inc. Outlines 2026 Strategic Priorities to Scale Impact, Expand Platform Reach, Advance Collaborative Drug Discovery, and Secure Development Partners
Reuters  ·  01-12 21:31
Schrödinger Inc. Outlines 2026 Strategic Priorities to Scale Impact, Expand Platform Reach, Advance Collaborative Drug Discovery, and Secure Development Partners
SchrÖDinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
THOMSON REUTERS  ·  01-12 21:30
SchrÖDinger Provides Update on Progress Across the Business and Outlines 2026 Strategic Priorities
Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target
MT Newswires Live  ·  01-12 20:40
Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target
Sophia Genetics sees Q4 revenue ‘at least’ $21M, consensus $20.5M
TIPRANKS  ·  01-12 20:17
Sophia Genetics sees Q4 revenue ‘at least’ $21M, consensus $20.5M
Sophia Genetics up 9% at $5.75 after Q4 and FY26 guidance
TIPRANKS  ·  01-12 20:15
Sophia Genetics up 9% at $5.75 after Q4 and FY26 guidance
SOPHiA GENETICS Projects 20-22% Revenue Growth for 2026
Reuters  ·  01-12 20:01
SOPHiA GENETICS Projects 20-22% Revenue Growth for 2026
Press Release: SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
Dow Jones  ·  01-12 20:00
Press Release: SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

Introduction

Company Name.
BK4167
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--